Exhibit 209 ยท Agency fact sheet
Diethylstilbestrol (DES) Exposure and Cancer
Soon after, the Food and Drug Administration (FDA) notified health care providers throughout the country that DES should not be prescribed to pregnant women
NCI fact sheet. It records that use of DES declined after studies in the 1950s showed it was not effective in preventing pregnancy complications, that researchers linked prenatal DES exposure to cancer in 1971, that the FDA soon afterward notified health care providers throughout the country that DES should not be prescribed to pregnant women, and the specific long-term health risks of exposure.
- Source
- National Cancer Institute
- Date
- Undated; accessed 9 November 2026
- Quoted from
- Introductory paragraph ("In 1971, researchers linked prenatal DES exposure ... Soon after, ...")
- Grade
- Primary record
- Document
- https://www.cancer.gov/about-cancer/causes-prevention/risk/hormones/des-fact-sheet
- Accessed
- 2026-11-09
- Cited by
- Findings citing this exhibit